Addex Therapeutics (ADXN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.76, -8.61% vs the prior close of $3.02.
- Volume 11.33K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ADXN slides 8.6% to $2.76. Closed at $2.76, -8.61% vs the prior close of $3.02. Day range $2.64–$3.19, opened at $3.10.
ADXN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ADXN slides 8.6% to $2.76
- Closed at $2.76, -8.61% vs the prior close of $3.02. Day range $2.64–$3.19, opened at $3.10.
- Volume was 11.33K shares, 0.1x its 50-day average of 177.31K — lighter than usual.
- Price is -28.9% vs its 50-day average ($3.88) and -54.4% vs its 200-day average ($6.06).
- 52-week range $2.56–$11.97; today's close sits at 2% of that range, 76.9% below the 52-week high.
Oct 15, 2026 — ADXN jumps 14.0% to $3.02
- Closed at $3.02, +13.96% vs the prior close of $2.65. Day range $2.75–$3.25, opened at $3.09.
- Volume was 36.70K shares, 0.2x its 50-day average of 176.58K — lighter than usual.
- Price is -23.4% vs its 50-day average ($3.94) and -50.3% vs its 200-day average ($6.08).
- 52-week range $2.56–$11.97; today's close sits at 5% of that range, 74.8% below the 52-week high.
Oct 14, 2026 — ADXN slides 12.0% to $2.65, a 52-week low, 3 down days in a row
- Closed at $2.65, -11.96% vs the prior close of $3.01. Day range $2.65–$3.06, opened at $2.97.
- Volume was 5.20K shares, 0.0x its 50-day average of 176.53K — lighter than usual.
- Price is -33.6% vs its 50-day average ($3.99) and -56.6% vs its 200-day average ($6.10).
- 52-week range $2.56–$11.97; today's close sits at 1% of that range, 77.9% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — ADXN dips 1.0% to $3.01
- Closed at $3.01, -0.99% vs the prior close of $3.04. Day range $2.98–$3.01, opened at $2.98.
- Volume was 1.20K shares, 0.0x its 50-day average of 176.50K — lighter than usual.
- Price is -25.8% vs its 50-day average ($4.05) and -50.9% vs its 200-day average ($6.13).
- 52-week range $2.56–$11.97; today's close sits at 5% of that range, 74.9% below the 52-week high.
Oct 12, 2026 — ADXN slides 5.6% to $3.04
- Closed at $3.04, -5.56% vs the prior close of $3.22. Day range $2.97–$3.20, opened at $3.08.
- Volume was 2.40K shares, 0.0x its 50-day average of 176.54K — lighter than usual.
- Price is -25.8% vs its 50-day average ($4.10) and -50.6% vs its 200-day average ($6.16).
- 52-week range $2.56–$11.97; today's close sits at 5% of that range, 74.6% below the 52-week high.
Oct 9, 2026 — ADXN rises 1.2% to $3.22
- Closed at $3.22, +1.23% vs the prior close of $3.18. Day range $3.09–$3.25, opened at $3.09.
- Volume was 4.50K shares, 0.0x its 50-day average of 176.51K — lighter than usual.
- Price is -22.3% vs its 50-day average ($4.14) and -47.9% vs its 200-day average ($6.18).
- 52-week range $2.56–$11.97; today's close sits at 7% of that range, 73.1% below the 52-week high.
Oct 8, 2026 — ADXN rises 1.6% to $3.18
- Closed at $3.18, +1.60% vs the prior close of $3.13. Day range $3.00–$3.23, opened at $3.22.
- Volume was 11.70K shares, 0.1x its 50-day average of 176.28K — lighter than usual.
- Price is -24.1% vs its 50-day average ($4.19) and -48.8% vs its 200-day average ($6.21).
- 52-week range $2.56–$11.97; today's close sits at 7% of that range, 73.4% below the 52-week high.
- SEC filings that day: 6-K.
Oct 7, 2026 — ADXN dips 1.6% to $3.13
- Closed at $3.13, -1.57% vs the prior close of $3.18. Day range $2.98–$3.16, opened at $3.14.
- Volume was 9.40K shares, 0.1x its 50-day average of 176.09K — lighter than usual.
- Price is -26.2% vs its 50-day average ($4.24) and -49.8% vs its 200-day average ($6.23).
- 52-week range $2.56–$11.97; today's close sits at 6% of that range, 73.9% below the 52-week high.
Oct 6, 2026 — ADXN rises 2.6% to $3.18, 4 up days in a row
- Closed at $3.18, +2.58% vs the prior close of $3.10. Day range $3.14–$3.20, opened at $3.15.
- Volume was 1.70K shares, 0.0x its 50-day average of 176.06K — lighter than usual.
- Price is -26.0% vs its 50-day average ($4.30) and -49.2% vs its 200-day average ($6.26).
- 52-week range $2.56–$11.97; today's close sits at 7% of that range, 73.4% below the 52-week high.
- That makes 4 straight gains.
Oct 5, 2026 — ADXN rises 1.0% to $3.10, 3 up days in a row
- Closed at $3.10, +0.98% vs the prior close of $3.07. Day range $3.10–$3.13, opened at $3.11.
- Volume was 5.90K shares, 0.0x its 50-day average of 175.94K — lighter than usual.
- Price is -28.8% vs its 50-day average ($4.35) and -50.6% vs its 200-day average ($6.28).
- 52-week range $2.56–$11.97; today's close sits at 6% of that range, 74.1% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — ADXN jumps 3.0% to $3.07
- Closed at $3.07, +3.02% vs the prior close of $2.98. Day range $2.99–$3.08, opened at $3.01.
- Volume was 13.40K shares, 0.1x its 50-day average of 175.67K — lighter than usual.
- Price is -30.4% vs its 50-day average ($4.41) and -51.3% vs its 200-day average ($6.30).
- 52-week range $2.56–$11.97; today's close sits at 5% of that range, 74.4% below the 52-week high.
- SEC filings that day: 6-K.
ADXN latest news & SEC filings
Every SEC filing by or about ADXN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 2, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 27, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 26, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade ADXN
- How much it moves: over the last 20 sessions the average daily move was 5.32% (largest 23.0%). That is a volatile stock.
- Liquidity: about 14.33K shares (≈$39.55K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.76 vs a range of $2.56–$11.97 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 8, 2026; 6-K Oct 2, 2026; 6-K Sep 28, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ADXN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.10 | 3.19 | 2.64 | 2.76 | 11.33K |
| Oct 15, 2026 | 3.09 | 3.25 | 2.75 | 3.02 | 36.70K |
| Oct 14, 2026 | 2.97 | 3.06 | 2.65 | 2.65 | 5.20K |
| Oct 13, 2026 | 2.98 | 3.01 | 2.98 | 3.01 | 1.20K |
| Oct 12, 2026 | 3.08 | 3.20 | 2.97 | 3.04 | 2.40K |
| Oct 9, 2026 | 3.09 | 3.25 | 3.09 | 3.22 | 4.50K |
| Oct 8, 2026 | 3.22 | 3.23 | 3.00 | 3.18 | 11.70K |
| Oct 7, 2026 | 3.14 | 3.16 | 2.98 | 3.13 | 9.40K |
| Oct 6, 2026 | 3.15 | 3.20 | 3.14 | 3.18 | 1.70K |
| Oct 5, 2026 | 3.11 | 3.13 | 3.10 | 3.10 | 5.90K |
| Oct 2, 2026 | 3.01 | 3.08 | 2.99 | 3.07 | 13.40K |
| Oct 1, 2026 | 2.83 | 2.98 | 2.78 | 2.98 | 5.70K |
| Sep 30, 2026 | 2.91 | 2.91 | 2.67 | 2.76 | 5.10K |
| Sep 29, 2026 | 2.74 | 2.97 | 2.69 | 2.95 | 31.30K |
| Sep 28, 2026 | 3.69 | 3.74 | 2.56 | 2.81 | 90.70K |
| Sep 25, 2026 | 3.62 | 3.80 | 3.52 | 3.65 | 15.30K |
| Sep 24, 2026 | 3.45 | 3.60 | 3.40 | 3.46 | 7.90K |
| Sep 23, 2026 | 3.48 | 3.54 | 3.42 | 3.45 | 12.80K |
| Sep 22, 2026 | 3.50 | 3.53 | 3.23 | 3.50 | 4.80K |
| Sep 21, 2026 | 3.35 | 3.53 | 3.34 | 3.53 | 9.60K |
About Addex Therapeutics
Addex Therapeutics (ADXN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in GENEVA, Switzerland. State of incorporation: Switzerland. Fiscal year ends December 31. SEC CIK 1574232.
ADXN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Timothy Mark Dyer | CHIEF EXECUTIVE OFFICER | Sep 4, 2026 |
| Raymond George Hill | Director | Sep 4, 2026 |
| Vincent Michael Lawton | Director | Sep 4, 2026 |
| Isaac Manke | Director | Sep 4, 2026 |
| Roger Mills | CHIEF MEDICAL OFFICER | Sep 4, 2026 |
| Jason Raleigh Nunn | Director | Sep 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Timothy Mark Dyer | CHIEF EXECUTIVE OFFICER | Sep 4, 2026 |
| Mikhail Kalinichev | HEAD OF TRANSLATIONAL SCIENCE | Sep 4, 2026 |
| Roger Mills | CHIEF MEDICAL OFFICER | Sep 4, 2026 |
| Lenaic Nathanael Teyssedou | PRINCIPAL ACCOUNTING OFFICER | Sep 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ADXN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
ADXN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ADXN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.